OAB

Astellas serves up dose of "reality" in DTC effort

Astellas serves up dose of "reality" in DTC effort

By

The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.

Astellas taps Roska for consumer OAB product launch

By

The agency announced the win Tuesday, just over a month after the FDA approval for extended-release tablet Myrbetriq.

DDR on DTC: Toviaz vs. Vesicare

DDR on DTC: Toviaz vs. Vesicare

Two brands are fighting for attention from OAB sufferers: GSK-Astellas's Vesicare and Pfizer's Toviaz. Their DTC approaches couldn't be more different.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.